Ocean Biomedical【OCEA】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.04015

買値

0.0401

売値

0.0402

出来高

8,483,795

0.037 日の範囲 0.042

0.0385 52 週間の範囲 2.09

時価総額

1.4M

前日終値

0.0432

始値

0.0418

時刻

619

0.04015

(formt)

最終取引時間

財務取引量

US$ 343,753

VWAP

0.040519

平均取引量 (3 か月)

58,464,696

発行済株式数

34,868,628

配当利回り

PER

-3.03

1 株当たり利益 (EPS)

-3.28

歳入

純利益

-114.47M

Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

セクター

Blank Checks

業界

Pharmaceutical Preparations

ウェブサイト

www.aestherhealthcarespac.com

本社

Dover, Delaware, USA

設立

2021

Ocean Biomedical Inc is listed in the Blank Checks sector of the ナスダック市場 with ticker OCEA. The last closing price for Ocean Biomedical was US$0.04. Over the last year, Ocean Biomedical shares have traded in a share price range of US$ 0.0385 to US$ 2.09.

Ocean Biomedical currently has 34,868,628 shares in issue. The market capitalisation of Ocean Biomedical is US$1.51 million. Ocean Biomedical has a price to earnings ratio (PE ratio) of -3.03.

Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China

PROVIDENCE, R.I., March 28, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a...

Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma Interest Providence, RI, Feb...

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

Providence, RI, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) announced today that its...

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today...

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

PROVIDENCE, Rhode Island, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today...

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Ocean Biomedical’s Anti-CHI3L1 patent coverage includes multiple methods of use for targeting a broad range of...

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms

Providence, RI, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that its...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.00685	-14.5744680851	0.047	0.048	0.04	7078020	0.04420413	CS
4	-0.01875	-31.8336162988	0.0589	0.136	0.0385	67273414	0.07725927	CS
12	-0.40185	-90.9162895928	0.442	0.6594	0.0385	58464696	0.12851254	CS
26	-0.94985	-95.9444444444	0.99	1.1	0.0385	27688185	0.13084654	CS
52	-1.73985	-97.7443820225	1.78	2.09	0.0385	13698742	0.13796689	CS
156	-9.91985	-99.5968875502	9.96	26.5986	0.0385	7655921	0.95086737	CS
260	-9.91985	-99.5968875502	9.96	26.5986	0.0385	7655921	0.95086737	CS

OCEA - Frequently Asked Questions (FAQ)

What is the current Ocean Biomedical share price?

The current share price of Ocean Biomedical is US$ 0.04015

How many Ocean Biomedical shares are in issue?

Ocean Biomedical has 34,868,628 shares in issue

What is the market cap of Ocean Biomedical?

The market capitalisation of Ocean Biomedical is USD 1.51M

What is the 1 year trading range for Ocean Biomedical share price?

Ocean Biomedical has traded in the range of US$ 0.0385 to US$ 2.09 during the past year

What is the PE ratio of Ocean Biomedical?

The price to earnings ratio of Ocean Biomedical is -3.03

What is the reporting currency for Ocean Biomedical?

Ocean Biomedical reports financial results in USD

What is the latest annual profit for Ocean Biomedical?

The latest annual profit of Ocean Biomedical is USD -114.47M

What is the registered address of Ocean Biomedical?

The registered address for Ocean Biomedical is 8 THE GREEN, STE A, KENT, DOVER, DELAWARE, 19901

What is the Ocean Biomedical website address?

The website address for Ocean Biomedical is www.aestherhealthcarespac.com

Which industry sector does Ocean Biomedical operate in?

Ocean Biomedical operates in the PHARMACEUTICAL PREPARATIONS sector

銘柄コード	株価	出来高
MSGMMotorsport Games Inc	US$ 2.69 (140.18%)	37M
SXTCChina SXT Pharmaceuticals Inc	US$ 2.11 (113.37%)	51.73M
ADGMAdagio Medical Holdings Inc	US$ 1.68 (81.98%)	115.48M
PNBKPatriot National Bancorp Inc	US$ 3.28 (73.54%)	1.57M
RTCBaijiayun Group Ltd	US$ 0.3601 (67.49%)	187.02M
LXEHLixiang Education Holding Company Ltd	US$ 8.25 (-64.11%)	1.55M
CLIKClick Holdings Ltd	US$ 0.355 (-48.18%)	13.52M
IOTRiOThree Ltd	US$ 1.1409 (-38.33%)	3.93M
FMTOFemto Technologies Inc	US$ 0.0191 (-35.47%)	198.4M
SISIShineco Inc	US$ 0.5809 (-35.07%)	824.91k
DMNDamon Inc	US$ 0.0034 (9.68%)	409.39M
STSSSharps Technology Inc	US$ 0.03195 (20.57%)	391.8M
SUNESUNation Energy Inc	US$ 0.0176 (-10.20%)	349.4M
NVDANVIDIA Corporation	US$ 101.49 (-2.87%)	292.48M
HTZHertz Global Holdings Inc	US$ 8.205 (43.70%)	266.91M

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Ocean Biomedical Inc (OCEA)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

Ocean Biomedical Inc について

OCEA 最新ニュース

Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China

Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms

Form 8-K - Current report

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Form 8-K - Current report

Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China

Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms

Form 8-K - Current report

OCEA - Frequently Asked Questions (FAQ)

ムーバー

OCEA Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Ocean Biomedical Inc (OCEA) 銘柄情報

Ocean Biomedical Inc (OCEA)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

Ocean Biomedical Inc について

OCEA 最新ニュース

Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China

Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms

Form 8-K - Current report

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Form 8-K - Current report

Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China

Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms

Form 8-K - Current report

OCEA - Frequently Asked Questions (FAQ)

ムーバー

OCEA Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

広告を削除する